Analyst Ratings for TrueBlue (TBI) [Neutrals]
TBI Rating Summary
TBI Price Target Summary
- Highest: $15.00 (BMO Capital)
- Lowest: $14.00 (Baird)
- Average: $14.50
* Over Last 12-Mos
Overall Rating:
NEUTRAL
Rating Trend:
Avg. $ Target:
$14.50 (+39.4%)
* Over Last 12-Mos
Rating Score: 4.3 / 10
Percentile Rank: 43%
Avg. $ Target:
$14.50 (+39.4%)
* Over Last 12-Mos
Rating Score: 4.3 / 10
Percentile Rank: 43%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 12/14/2020 | Northcoast Research | John Healy | Downgrade | Neutral (Buy) |
N/A (N/A) |
20.24 (10.40) |
-48.62% | Details |
| 8/10/2018 | Credit Suisse » Updated 4/27/2021 |
Kevin McVeigh | New Coverage | Neutral (N/A) |
23.00 (19.00) |
28.35 (10.40) |
-63.32% | Details |
 |
||||||||
|
||||||||
